Skip to main content
. 2012 Feb 15;37(7):1632–1646. doi: 10.1038/npp.2012.8

Table 3. Mean (SD) Scores on the PANSS, CADSS, and VAS Across Dose Condition and Time.

  Placebo
0.015 mg/kg THC
0.03 mg/kg THC
  Baseline +10 min +80 min Baseline +10 min +80 min Baseline +10 min +80 min
Measure
 PANSS
  Positive 7.42 (1.06) 7.96 (2.18) 7.23 (0.51) 7.31 (0.68) 10.73 (2.65) 8.38 (1.77) 7.08 (0.27) 12.65 (3.19) 9.46 (2.37)
  Negative 6.92 (1.44) 7.58 (2.30) 7.23 (1.45) 6.42 (0.76) 9.12 (2.20) 7.23 (1.34) 6.54 (1.03) 11.73 (3.56) 9.00 (2.30)
  General 15.42 (1 14) 17.12 (2 92) 15.65 (1 13) 15.23 (0 43) 20.77 (4 09) 17.50 (3 08) 15.31 (0 88) 25.65 (6 30) 19.42 (3 25)
  Total 29.77 (3.35) 32.65 (5.38) 30.12 (2.44) 28.96 (1.18) 40.62 (7.39) 33.12 (5.01) 28.92 (1.60) 50.04 (10.52) 37.88 (6.49)
                   
 CADSS
  CR 0.15 (0.61) 0.85 (1.59) 0.04 (0.20) 0.04 (0.20) 2.92 (2.19) 1.00 (1.52) 0.04 (0.20) 6.38 (4.21) 2.46 (2.30)
  PR 0.08 (0.39) 0.77 (2.41) 0.31 (0.88) 0.12 (0.33) 3.65 (4.15) 2.31 (3.60) 0.00 (0.00) 9.69 (10.20) 4.92 (6.19)
                   
 VAS
  High 1.85 (2.91) 9.65 (21.99) 6.92 (16.26) 1.81 (2.61) 40.90 (29.89) 20.35 (22.54) 1.56 (2.15) 62.40 (28.42) 37.19 (27.60)

Abbreviations: CADSS, Clinician-Administered Dissociative Syndrome Scale; Clinician Rated (CR) and Patient Rated (PR); PANSS, Positive and Negative Syndrome Scale; VAS, Visual Analog Scale.